Becoming Aware of Feelings with David A. Garfield and Richard D. Lane at NYPSI
By Categories: Announcements

NEW YORK PSYCHOANALYTIC SOCIETY & INSTITUTE:
Arnold Pfeffer Center for Neuropsychoanalysis
Marianne and Nicholas Young Auditorium
247 East 82nd St., between 2nd & 3rd, NY, NY 10028
212-879-6900
www.psychoanalysis.org

Saturday, December 1, 2012, 10 am – 12 pm, Donations accepted

Becoming Aware of Feelings: Integration of Cognitive-Developmental,
Neuroscientific & Psychoanalytic Perspectives

David A. Garfield, M.D.
Rosalind Franklin University for Medicine and Science/The Chicago Medical School, and the Chicago Institute for Psychoanalysis

Richard D. Lane, M.D., Ph.D.
University of Arizona Continue reading Becoming Aware of Feelings with David A. Garfield and Richard D. Lane at NYPSI

Why Doesn’t it Always Last in Love? with Samara Kaufmann Kolstein at AIP
By Categories: Uncategorized

THE ASSOCIATION FOR THE ADVANCEMENT OF PSYCHOANALYSIS
Of The Karen Horney Psychoanalytic Center
___________________________________________________________

PUBLIC EDUCATION LECTURES 2012-2013

Friday, December 7, 2012 at 8:00 PM: WHY DOESN’T IT ALWAYS LAST IN LOVE? AND HOW DO WE RETRIEVE IT? Samara Kaufmann Kolstein, MA Continue reading Why Doesn’t it Always Last in Love? with Samara Kaufmann Kolstein at AIP

Analytic Work with Beauty Addicts with Anita Katz at APsaA Meeting
By Categories: Announcements

Co-chairs Ellen Sinkman and Arlene Kramer Richards invite you to participate in a Discussion Group, #47,  on

Beauty and Body in Therapeutic Work. This year Janice Lieberman, PhD, will present on “Analytic Work with Beauty Addicts.”
 
It will be held Wednesday, January 16, 2013, 7:00-9:00 p.m. at the national meeting of the American Psychoanalytic Association  at the Waldorf Astoria Hotel. 

Running (from) Depression: a Controlled study vs. Sertraline
By Categories: Science News

What is that is going on (in) here, psychoanalytically: Lower remission rate with excercise vs. Sertraline. We have more to learn about this thing called “depression.”

NSzajnberg, MD Managing Editor

Dr. Noordsy referenced a study from researchers at Duke University in which 156 patients with major depressive disorder (MDD) were randomly assigned either to aerobic exercise, sertraline therapy (50 mg to 200 mg), or both for 4 months. Continue reading Running (from) Depression: a Controlled study vs. Sertraline